Target intelligence / Profile preview

Fluorine-19 (19F)

Target
19F
Molecular classification
Other
01

Overview

Fluorine-19 is the only stable, naturally occurring isotope of fluorine and is widely utilized in medicinal chemistry and diagnostic imaging rather than serving as a therapeutic target itself (O'Hagan, 2008, Journal of Fluorine Chemistry). It possesses a nuclear spin of 1/2 and a high gyromagnetic ratio, making it an ideal nucleus for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) spectroscopy, as there is virtually no endogenous background signal in the human body (Ruiz-Cabello et al., 2011, NMR in Biomedicine). In the pharmaceutical industry, approximately 20-30% of all approved drugs contain at least one fluorine atom to improve metabolic stability, modulate lipophilicity, and increase binding affinity (Zhou et al., 2016, Chemical Reviews). While Fluorine-19 is not a receptor or enzyme, its incorporation into drugs allows for the non-invasive monitoring of pharmacokinetics and drug distribution in vivo. Unlike the radioactive isotope Fluorine-18 used in PET imaging, Fluorine-19 is stable and does not involve ionizing radiation, making it suitable for long-term longitudinal studies (Purser et al., 2008, Nature). Consequently, it is a vital tool for biotech analysts and researchers focusing on drug delivery systems, cell tracking, and molecular imaging.

Other names
19FStable fluorine isotopeFluorine-19 isotope
02

Mechanism of action

Not applicable

03

Biological functions

Other
04

Safety considerations

Metabolic defluorination leading to fluoride ion releasePotential for skeletal fluorosis with chronic high-dose exposure to fluoride ions
05

Biomarkers

19F-MRI signal intensityTrifluoromethyl group (CF3) NMR chemical shift

Beyond the preview

Go deeper on Fluorine-19 (19F).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fluorine-19 (19F).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call